Facing Covaxin shortfall, K'taka to give second dose only to 45+ age group

The Karnataka government, in order to tide over a shortfall in Covaxin stock in the state, has directed health officials to administer the second dose of Covid vaccine only to people above 45 years

Bharat Biotech, Covaxin, Covid-19
ANI General News
2 min read Last Updated : May 25 2021 | 11:11 AM IST

The Karnataka government, in order to tide over a shortfall in Covaxin stock in the state, has directed health officials to administer the second dose of Covid-19 vaccine only to people aged above 45 years.

In an official order on Monday the state government said: "In order to tide over the current situation of short supply of Covaxin in the State of Karnataka, it is hereby advised that all the private health care institutions should utilize the available stock of Covaxin at their respective health facility, as the second dose for the age group 45 plus who are awaiting for the second dose of Covaxin as per the COVID vaccination schedule of Government of India."

Karnataka recorded 25,311 fresh Covid-19 cases, 57,333 discharges and 529 deaths in the last 24 hours, as per the state health bulletin yesterday. The active cases in the state stand at 4,40,435.

The state is also witnessing a surge in black fungus cases. Karnataka has reported 446 cases of mucormycosis or black fungus infections and 12 related fatalities so far, the state's Health and Medical Education Minister K Sudhakar said yesterday.

Following this, Union Minister for Chemicals and Fertilisers DV Sadananda Gowda announced that an additional 1,030 vials of Amphotericin-B, a drug used to treat black fungus, have been allocated to Karnataka. Gowda took to Twitter and informed about the allocation of drugs.

Three days ago, the Karnataka government extended the statewide lockdown to contain the spread of Covid-19 till 6 am on June 7.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineKarnataka

First Published: May 25 2021 | 11:06 AM IST

Next Story